“In Malaysia, cervical cancer is the second most common cancer among women aged 15 to 44. In 2020 alone, there were 1,740 new cases reported, with a mortality rate of 57%. These alarming figures are largely due to challenges like cultural stigmas, invasive screening techniques, patient preferences, and lack of awareness, all of which hinder the progress of cervical cancer screening uptakes. 

PapLite Pro™ represents a potential game-changer in cervical screening for healthcare professionals, offering a more technologically advanced version for enhanced visualisation and precision of cell sampling ,” said Dr Kavinash Loganathan, Research Coordinator at the National Cancer Society of Malaysia.

The launch of PapLite Pro™ brought together industry partners, medical professionals, researchers, and advocates to advance women's health through innovative technology. 

In her welcome speech, Dr Thian Lok Boon, Pro Vice-Chancellor of Learning & Teaching at Taylor’s University mentioned, “Taylor’s has embarked on a journey to be a purpose-driven university – and we do it through our education, research and advocacy. The implementation of purpose-led learning across all our schools saw us introducing 11 Impact Labs. Each Impact Lab consists of solution-focused transdisciplinary teams of academics, industry, and students, collaborating to bring meaningful ideas to life. Our commitment to address societal challenges and bring change to various communities is embodied within Taylor’sphere.”